Discover Antimicrobial Stewardship

Together, we can change the course of antimicrobial resistance

The threat of drug-resistant bacteria continues to grow — and so does our commitment  to helping you combat this global issue. As a
leader in diagnostics for more than 50 years, we have made it our mission to innovate and advocate for better antimicrobial stewardship. 

Discover how Roche can help you bring insights and innovative solutions to your institution’s antimicrobial stewardship program.

alt

 

Antibiotics are an important treatment option, but their misuse is causing devastating impact.

Antimicrobial stewardship map

In 2021, the CDC published an updated report on the progress the US is making on overall antimicrobial stewardship efforts.

alt

Roche offers a broad portfolio of products which can enable better clinical decisions and therefore appropriate antimicrobial use.
Click on the products below to learn more!

cobas® Liat® PCR System

cobas® Liat® PCR System

Treat common infections with confidence at the earliest possible convenience.

Elecsys® BRAHMS PCT Assay

Elecsys® BRAHMS PCT Assay

 

cobas® MRSA/SA | Cdiff Tests

cobas® MRSA/SA | Cdiff Tests

Identify and contain healthcare-associated infections (HAIs).

Accuracy and speed that 
support antimicrobial stewardship

The system is positioned to provide accurate, actionable results at the point of care. Whether results are positive or negative, you can confidently treat patients without the need to wait for confirmation.

SARS-CoV-2*

SARS-CoV-2 & Influenza A/B*

Influenza A/B & RSV

Group A Strep

C. Difficile**

 

See more about the Liat®

Help determine if antibiotics are needed or if certain bacterial infections are resolving.

The Elecsys BRAHMS PCT solution aids in assessing the mortality risk of patients fighting sepsis and guiding antibiotic decision-making for patients with lower respiratory tract infections, like pneumonia, bronchitis, COPD and sepsis.5,6

 

See more

Timely and cost-effective molecular solutions for improved HAI management

The cobas MRSA/SA and Cdiff tests provide provide excellent performance and broad coverage to increase confidence in HAI testing. Run on the fully automated cobas 4800 system, these assays may help your institution control infections and costs.

✓ Decrease transmission
✓ Reduce antibiotic use over time
 

cobas® MRSA/SA Test

cobas® Cdiff Test

alt

 

See how one customer used the cobas® Liat system to improve their Strep A testing 

liat

 

Want to learn more?  Click on the webinar links below.

A New Year's Resolution: Become a Better Antibiotic Steward
A New Year's Resolution: Become a Better Antibiotic Steward
 

Watch now

Procalcitonin Testing and Molecular Pathogen Detection: A Value Model
Procalcitonin Testing and Molecular Pathogen Detection: A Value Model
 

Watch now

Influenza Testing - Impact of New Testing and New Testing Options
Influenza Testing: Impact of New Testing and New Testing Options
 

Watch now

Testing Strategies for Group A Strep – Out with the Old, in with the New?
Testing Strategies For Group A Strep: Out With The Old, In With The New?
 

Watch now

Increasing STI Screening Coverage by Focusing on the End Users: Clinicians and Patients
Increasing STI Screening Coverage by Focusing on the End Users: Clinicians and Patients
 

Watch now

FDA Reclassification of Rapid Antigen Flu Testing
FDA Reclassification of Rapid Antigen Flu Testing
 

Watch now

Looking for CME credit?  We have partnered with Medscape on the 4 following Antibiotic Stewardship related webinars:

strep-a

Shifting the Paradigm:
Rethinking Our Approach to Diagnosing Group A Strep Pharyngitis

View now

PCT

Antibiotic Stewardship in Focus A Closer Look at Procalcitonin-Guided Antibiotic De-Escalation

View now

abs-liat

Testing Strategies For Group A Strep:
Out With The Old, In With The New?

View now

flu

Key Considerations in Diagnosing the Flu

View now

alt

External links and resources to help you with your Antimicrobial Stewardship initiatives

SHEA-logo
Want to learn more about Roche products and solutions to better enable Antimicrobial Stewardship?
CONTACT US

References

  1. Centers for Disease Control and Prevention.    https://www.cdc.gov/drugresistance/national-estimates.html, accessed May 9, 2022.
  2. Centers for Disease Control and Prevention. “1 in 3 antibiotic prescriptions unnecessary.” CDC Newsroom. https://www.cdc.gov/antibiotic-use/stewardship-report/outpatient.html (accessed October  23, 2019).
  3. IMS Health. Avoidable Costs in U.S. Healthcare. Danbury, CT: IMS Health; 2013. 
  4. Centers for Disease Control and Prevention.  https://www.cdc.gov/hai/data/portal/index.html, accessed October 23, 2019
  5. Elecsys BRAHMS PCT [package insert]. Indianapolis, IN: Roche Diagnostics; 2016.

 

* This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA.

** This product has been approved by FDA for use by authorized laboratories certified under CLIA to perform moderate complexity testing.

COBAS, LIAT, ELECSYS and VIEWICS are trademarks of Roche.

© 2022 Roche Diagnostics, North America. All rights reserved.